PATENT CLAIM ANALYSIS

Application Number: 15874396
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "044000"]

Abstract:
The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.

Claim (Index 23):
A composition comprising an iRNA agent comprising a sense strand and an antisense strand, wherein: the antisense strand comprises a nucleotide sequence of nucleotides 2-18 of any of the antisense strands Table 1A, Table 1B, Table 1C, or Table 1D.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.27273
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15260824', '12683146', '14729104', '12771614', '12771566']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8129517831025754
- 35 USC 102 Novelty (BERT): 0.5496883424492273
- Combined Prediction Score: 0.7866254390372406
- Mean Citation Score: 410.52154
- Max Citation Score: 416.51477
- Similarity Product: 358.029669440372

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test